Department of Diagnostic and Interventional Radiology, St James's University Hospital, Leeds, UK.
Department of Medical Physics - Engineering, St James's University Hospital, Leeds, UK.
Diagn Interv Radiol. 2021 Mar;27(2):244-248. doi: 10.5152/dir.2021.19548.
We aimed to evaluate the effect on the radiation dose to the patient by reducing the tube current during the placement of the ablation needles (reduced dose group) compared with the patient doses delivered when scanning at the standard fully diagnostic level (full dose group) in computed tomography (CT)-guided percutaneous cryoablation.
We conducted a retrospective study of 103 patients undergoing cryoablation in a tertiary cancer center. Overall, 62 patients were scanned with standard exposure parameters (full dose group) set on a 64-slice multidetector CT scanner, while 41 patients were scanned on a reduced dose protocol. Dose levels were retrieved from the hospital picture and archiving communication system including the volumetric CT dose index (CTDIvol), total dose length product (DLP), length of cryoablation procedure, number of cryoablation needles and patient size. Wilcoxon Mann-Whitney (rank-sum) tests were used to compare the median DLP, CTDIvol and skin dose between the two groups.
Median total DLP for the full dose group was 6025 mGy•cm (1909-13353 mGy•cm) compared with 3391 mGy•cm (1683-6820 mGy•cm) for the reduced dose group. The reduced dose group had a 44% reduction in total DLP and 42% reduction in total CTDIvol (p < 0.001). The estimated skin doses were 384 mGy for the full dose group and 224 mGy for the reduced dose group (42% reduction) (p < 0.001). At 12-month follow-up, the technical success for the full dose (n=62) was 97% with 2 patients requiring a further cryoablation treatment for residual tumor. The technical success for the reduced dose group (n=41) was 100%.
CT dose reduction technique during image-guided cryoablation treatment of renal tumors can achieve significant radiation dose reduction whilst maintaining sufficient image quality.
我们旨在评估在 CT 引导下经皮冷冻消融过程中降低消融针放置时的管电流(降低剂量组)对患者辐射剂量的影响,与在标准全诊断水平(全剂量组)下进行扫描时为患者提供的剂量进行比较。
我们对在一家三级癌症中心接受冷冻消融的 103 名患者进行了回顾性研究。共有 62 名患者使用 64 层多排 CT 扫描仪设置标准曝光参数(全剂量组)进行扫描,而 41 名患者则使用降低剂量方案进行扫描。剂量水平从医院的图像和归档通信系统中检索,包括容积 CT 剂量指数(CTDIvol)、总剂量长度乘积(DLP)、冷冻消融程序的长度、冷冻消融针的数量和患者的体型。使用 Wilcoxon 曼-惠特尼(秩和)检验比较两组的中位数 DLP、CTDIvol 和皮肤剂量。
全剂量组的总 DLP 中位数为 6025 mGy•cm(1909-13353 mGy•cm),而降低剂量组为 3391 mGy•cm(1683-6820 mGy•cm)。降低剂量组的总 DLP 降低了 44%,总 CTDIvol 降低了 42%(p<0.001)。全剂量组的估计皮肤剂量为 384 mGy,而降低剂量组为 224 mGy(降低了 42%)(p<0.001)。在 12 个月的随访中,全剂量组(n=62)的技术成功率为 97%,2 名患者因残余肿瘤需要进一步的冷冻消融治疗。降低剂量组(n=41)的技术成功率为 100%。
在 CT 引导下冷冻消融治疗肾肿瘤过程中使用 CT 剂量降低技术可以显著降低辐射剂量,同时保持足够的图像质量。